National & International Grants

National & International Grants

Current Nationally Funded Projects

FFG (Österreichische Forschungsförderungsgesellschaft)

Platform supporting an integrated analysis of image and multi-OMICs data based on liquid biopsies for tumor diagnostics (VISIOMICS)
Labdia coordinator: Sabine Taschner-Mandl, Peter Ambros
Coordinator: Julian Mattes (Software Competence Center Hagenberg GmbH, Austria)
Grant from the Austrian Research Promotion Agency (FFG), COIN Programme
N°: 861750 | Duration: 01/11/2017 to 31/10/2019

Establishing a zebrafish disease model drug screening platform, (Danio4Can)
CCRI responsible principal investigator: Martin Distel
Grant from the Austrian Research Promotion Agency (FFG), R&D Infrastrukturförderung, 1st Call
N°: 858071 | Duration: 01/05/2017 to 30/04/2019

Advancing Liquid Biopsies for Monitoring and Personalized Treatment of Children with Neuroblastomas
Coordinator: Sabine Taschner-Mandl (CCRI)
Grant from the FWF under the ERA-NET TRANSCAN-2 initiative
N°: I 4162-B| Duration: 01/01/2019 to 31/12/2021

Find Tumor immune evasion strategies by cellular barcoding
CCRI responsible principal investigator: Eva Maria König (neé EM Putz)
Grant from the Austrian Science Fund (FWF), Stand Alone Project
N°: P-32001-B| Duration: 01/01/2019 to 31/12/2021

Role of stress granules in Ewing sarcoma susceptibility
CCRI responsible principal investigator: Heinrich Kovar
Grant from the Austrian Science Fund (FWF), Stand Alone Project
N°: P-29773-B28| Duration: 01/06/2017 to 31/05/2020

Ewing sarcoma – an enhancer disease?
CCRI responsible principal investigator: Eleni Tomazou
Grant from the Austrian Science Fund (FWF), Elise Richter Programme
N°: V 506 B28 | Duration: 01/01/2016 to 31/12/2019

 

Ultra-high-risk pediatric cancer - combinatorial drivers and therapeutic targets for precision medicine
CCRI principal investigator: Sabine Taschner-Mandl
Grant from the WWTF, Life Sciences Call 2018
N°: LS18--111 | Duration: 01/01/2018 to 31/12/2021

Characterizing and targeting the Ewing sarcoma microenvironment to overcome resistance to therapy
CCRI principal investigator: Eleni Tomazou
Grant from the WWTF, Life Sciences Call 2018
N°: LS18--049 | Duration: 01/01/2018 to 31/12/2021

Epigenetische Tumor-Heterogenität bei der Behandlung des Ewing-Sarkoms mit Chemotherapie
CCRI responsible principal investigator: Eleni Tomazou
Grant from the Austrian National Bank (OeNB), Jubiläumsfonds
N°: 17876 | Duration: 01/09/2018 to 31/08/2021

Current Internationally Funded Projects

Expert Paediatric Oncology Reference Network for Diagnostics and Treatment (ExPO-r-Net)
Coordinator: Ruth Ladenstein (CCRI)
Grant from the European Consumers, Health, Agriculture and Food Executive Agency (CHAFEA)
N°: 20131207 | Duration: 01/03/2014 to 28/02/2017

Optimized Diagnostics for Improved Treatment Stratification in Invasive Fungal Diseases (FUNGITECT)
Coordinator: Thomas Lion (CCRI/Labdia)
European Commission Grant - FP7 Cooperation Project
N°: 278514 | Duration: 01/02/2014 to 31/01/2018

Automation of Flow Cytometric Analysis for Quality-Assured Follow-up Assessment to Guide Curative Therapy for Acute Lymphoblastic Leukaemia in Children (AutoFLOW)
Labdia/CCRI partner: Michael Dworzak
Coordinator: Martin Kampel (Technical University of Vienna, Austria)
European Commission Grant - FP7 Industry-Academia Partnerships and Pathways (Marie Curie Actions)
N°: 610872 | Duration: 01/02/2014 to 31/01/2018

Molecular Mechanisms of Human Fungal Pathogen Host Interaction (ImResFun)
CCRI partner: Thomas Lion
Coordinator: Karl Kuchler (Medical University of Vienna, Austria)
European Commission Grant - FP7 Initial Training Network (Marie Curie Actions)
N°: 606786 | Duration: 01/10/2013 to 30/09/2017

EURO EWING Consortium – International Clinical Trials to Improve Survival from Ewing Sarcoma (EEC)
CCRI partner: Heinrich Kovar
Coordinator: Jeremy Whelan (University College London, UK)
European Commission Grant - FP7 Cooperation Project
N°: 602856 | Duration: 01/09/2013 to 31/08/2018

Targeted Modulation of Immune-System Responses in Cell Therapies (MODICELL)
Coordinator: Originally Andreas Heitger (5 May 2014), presently Wolfgang Holter
European Commission Grant - FP7 Industry-Academia Partnerships and Pathways (Marie Curie Actions)
N°: 285875 | Duration: 01/01/2013 to 31/12/2016

International study for treatment of childhood relapsed ALL 2010 (IntReALL)
CCRI partners: Georg Mann, Andishe Attarbaschi and Ruth Ladenstein
Coordinator: Jeremy Whelan (University College London, UK)
European Commission Grant - FP7 Cooperation Project
N°: 278514 | Duration: 01/10/2011 to 31/09/2016

PanCare Childhood and Adolescent Cancer Survivor Care and Follow-up Studies (PanCareSurFup)
CCRI/St Anna Spital partners: Eva Frey
Coordinator: Lars Hjorth (Lund University, Sweden)
European Commission Grant - FP7 Cooperation Project
N°: 257505 | Duration: 01/02/2011 to 31/01/2016

European Network for Cancer Research in Children and Adolescents (ENCCA)
CCRI partners: Ruth Ladenstein, Peter Ambros, Michael Dworzak and Heinrich Kovar
Coordinator: Ruth Ladenstein (CCRI)
European Commission Grant - FP7 Network of Excellence
N°: 261474 | Duration: 01/01/2011 to 31/12/2014

Analysing and Striking the Sensitivities of Embryonal Tumours (ASSET)
CCRI partner: Heinrich Kovar
Coordinator: Walter Koch (University College Dublin, Ireland)
European Commission Grant - FP7 Cooperation Project
N°: 259348 | Duration: 01/11/2010 to 31/10/2015